Home » State News » COVID-19 Drugs Favipiravir And Remdesivir To Be Available In Odisha

COVID-19 Drugs Favipiravir And Remdesivir To Be Available In Odisha

Bhubaneswar:12/9/20: Here’s good news amidst rising number of COVID-19 fatalities in Odisha, as the Drugs Controller General of India (DCGI) has allowed for sale of Favipiravir Tablet and Remdesivir Injectable Formulation  in stores for the treatment of persons infected with the COVID-19.

However, the drug will be sold to the public with certain restrictions, the Directorate of Drugs Control, Odisha, informed today.

As per conditions set by the DCGI for sale of COVID-19 drug and injection to patients, the medicine will be sold under prescription by the doctors and it will be available to the patient or patient’s representative following furnishing residence proof.

The market sale of Favipiravir Tablet and Remdesivir Injectable Formulation is allowed in Odisha on following conditions:

1. The drug will be sold under prescription of medical specialists

2. Informed consent of the patient or his/her representative in the prescribed form is mandatory before initiating the treatment

3. The drug will be made available to the patient/ his representative only through in-house retail chemists attached to hospitals/nursing homes having valid drug licences. Where there is no in-house retail chemist shop in the hospital/ nursing home, the local Drugs Inspector will identify one or more retail chemist shop through whom the drugs will be made available.

4. The retail chemist shop will mandatorily retain a photocopy of the prescription, photocopy of written consent of the patient or his/her representative, residential proof of the purchaser and his/her contact details before supply of the medicines as record for verification in addition to fulfilment of other conditions under the Drugs and Cosmetics Rules.

5. Remdesivir formulations are required to be supplied for use only to the hospitals/institutions to ensure proper use of the drug under the Restricted Emergency Use. In no case Remdesivir formulation is to be sold to any patient/his representative directly.

6. The retail chemist shall furnish details of purchase/ sell of the above drugs to the respective range Drugs Inspector on a weekly basis.


About Editor in chief

Ashok Palit has completed his graduation from Upendranath College Soro, Balasore and post graduation from Utkal University in Odia Language and literture.. He has also carved out a niche for himself as a scribe of eminence after joining the profession in 1988. He is also an independent media production professional. He brings loads of experience to Advanced Media, Ashok Palit as a cineaste has been active in film criticism for over three decades. As a film society activist, he soared to eminence for his profound commitment to the art film appreciation and aesthetics of cinema. His mode of discourse is often erudite but always lucid and comprehensible marked by a perfect acumen so rare in the field. A film aesthete with an immense fond of critical sensibilities, he wrote about growth and development of odia cinema in New Indian Express, The Times of India, The Hindustan Times, The Asian Age and Screen. He has been working as an Editor for Cine Samaya from 2002-2004.. He had made solid contribution on cinema in many odia Dailies and weekly such as Samaj, Prajatantra, Dharatri, Samaya, Satabadi, and weekly Samaya.

Check Also

Jajpur would become the number one district in the state and will create a role model for all:Naveen Patnaik

Bhubaneswar:8/2/123: Jajpur would become the number one district in the state and will create a role model for all, said Chief Minister Naveen Patnaik on Wednesday.While inaugurating the Jajpur Mahotsav- ...